Marinus Pharmace (MRNS) Stock Price, News & Analysis
Company Description
Marinus Pharmace (NASDAQ: MRNS) is classified in the pharmaceutical preparation manufacturing industry within the Pharmaceutical Preparations sector and carries a market capitalization of $30.0M, ranking #6,137 among all listed U.S. companies by market cap.
MRNS has declined 94.5% over the past year. Shares last traded at $0.5500.
This page collects what Stock Titan holds for MRNS, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Marinus Pharmace (MRNS) stock last closed at $0.5500. Over the past 12 months, the stock has lost 94.5%. At a market capitalization of $30.0M, MRNS is classified as a micro-cap stock with approximately 55.2M shares outstanding.
MRNS Rankings
Latest News
Marinus Pharmace has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, earnings, clinical trial, conferences. View all MRNS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
MRNS Company Profile & Sector Positioning
Marinus Pharmace (MRNS) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.